BlackRock
HIMS icon

BlackRock’s Hims & Hers Health HIMS Stock Holding History

BlackRock’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$995M Buy
28,703,514
+2,366,356
+9% +$63.5M 0.01% 779
2026
Q1 		$547M Sell
26,337,158
-236,346
-0.9% -$5.58M 0.01% 1038
2025
Q4 		$863M Buy
26,573,504
+1,427,690
+6% +$61.2M 0.01% 762
2025
Q3 		$1.43B Buy
25,145,814
+396,440
+2% +$20.3M 0.03% 539
2025
Q2 		$1.23B Buy
24,749,374
+504,737
+2% +$22.8M 0.02% 563
2025
Q1 		$716M Sell
24,244,637
-5,862,886
-19% -$218M 0.02% 798
2024
Q4 		$728M Buy
30,107,523
+14,689,018
+95% +$364M 0.01% 822
2024
Q3 		$284M Buy
15,418,505
+844,408
+6% +$15.1M 0.01% 1453
2024
Q2 		$294M Buy
14,574,097
+3,713,605
+34% +$61.8M 0.01% 1360
2024
Q1 		$168M Buy
10,860,492
+1,109
+0% +$12.5K ﹤0.01% 1760
2023
Q4 		$96.6M Buy
10,859,383
+513,698
+5% +$3.8M ﹤0.01% 2099
2023
Q3 		$65.1M Buy
10,345,685
+416,624
+4% +$3.1M ﹤0.01% 2249
2023
Q2 		$93.3M Buy
9,929,061
+991,959
+11% +$9.83M ﹤0.01% 2084
2023
Q1 		$88.7M Sell
8,937,102
-141,624
-2% -$1.24M ﹤0.01% 2090
2022
Q4 		$58.2M Buy
9,078,726
+726,956
+9% +$4.14M ﹤0.01% 2358
2022
Q3 		$46.6M Sell
8,351,770
-120,105
-1% -$724K ﹤0.01% 2492
2022
Q2 		$38.4M Buy
8,471,875
+6,185,560
+271% +$26.4M ﹤0.01% 2666
2022
Q1 		$12.2M Sell
2,286,315
-29,385
-1% -$145K ﹤0.01% 3470
2021
Q4 		$15.2M Buy
2,315,700
+163,791
+8% +$1.18M ﹤0.01% 3434
2021
Q3 		$16.2M Buy
2,151,909
+833,033
+63% +$7.06M ﹤0.01% 3420
2021
Q2 		$14.4M Sell
1,318,876
-137,937
-9% -$1.64M ﹤0.01% 3491
2021
Q1 		$19.3M Buy
1,456,813
+1,452,081
+30,686% +$24.3M ﹤0.01% 3206
2020
Q4 		$69K Buy
+4,732
New +$52.5K ﹤0.01% 4633

Other funds holding HIMS

Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BlackRock's HIMS Position: Q2 2026 in Review

BlackRock increased its Hims & Hers Health (HIMS) stake by 9% in Q2 2026, buying an estimated $63.5M and bringing the position to 28,703,514 shares worth $995M. The position accounts for 0.01% of the portfolio, ranked #779.

BlackRock first reported a position in HIMS in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.43B in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • BlackRock held 28,703,514 shares of Hims & Hers Health worth $995M as of Q2 2026.
  • BlackRock bought 2,366,356 Hims & Hers Health shares in Q2 2026, an estimated $63.5M.
  • Hims & Hers Health made up 0.01% of BlackRock's portfolio in Q2 2026, its #779 holding.
  • BlackRock first reported a position in Hims & Hers Health in Q4 2020 and has held it in 23 quarters since.
  • BlackRock's Hims & Hers Health position peaked at $1.43B in Q3 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.